Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Amortization of Deferred Charges (2023 - 2025)

SeaStar Medical Holding's Amortization of Deferred Charges history spans 3 years, with the latest figure at $7000.0 for Q2 2025.

  • For Q2 2025, Amortization of Deferred Charges fell 76.67% year-over-year to $7000.0; the TTM value through Dec 2025 reached $18000.0, down 82.35%, while the annual FY2025 figure was $18000.0, 82.35% down from the prior year.
  • Amortization of Deferred Charges reached $7000.0 in Q2 2025 per ICUCW's latest filing, down from $11000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $45000.0 in Q3 2024 to a low of $4000.0 in Q1 2023.
  • Average Amortization of Deferred Charges over 3 years is $18666.7, with a median of $14000.0 recorded in 2023.
  • Peak YoY movement for Amortization of Deferred Charges: surged 575.0% in 2024, then tumbled 76.67% in 2025.
  • A 3-year view of Amortization of Deferred Charges shows it stood at $11000.0 in 2023, then skyrocketed by 309.09% to $45000.0 in 2024, then crashed by 84.44% to $7000.0 in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Amortization of Deferred Charges are $7000.0 (Q2 2025), $11000.0 (Q1 2025), and $45000.0 (Q3 2024).